JP2022501046A5 - - Google Patents
Info
- Publication number
- JP2022501046A5 JP2022501046A5 JP2021516368A JP2021516368A JP2022501046A5 JP 2022501046 A5 JP2022501046 A5 JP 2022501046A5 JP 2021516368 A JP2021516368 A JP 2021516368A JP 2021516368 A JP2021516368 A JP 2021516368A JP 2022501046 A5 JP2022501046 A5 JP 2022501046A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cancer
- polynucleotide
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1815549.9 | 2018-09-24 | ||
| GBGB1815549.9A GB201815549D0 (en) | 2018-09-24 | 2018-09-24 | Arginase1 polypeptides |
| PCT/EP2019/075731 WO2020064744A1 (en) | 2018-09-24 | 2019-09-24 | Arginase1 polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022501046A JP2022501046A (ja) | 2022-01-06 |
| JP2022501046A5 true JP2022501046A5 (enExample) | 2022-08-30 |
| JP7624388B2 JP7624388B2 (ja) | 2025-01-30 |
Family
ID=64024184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516368A Active JP7624388B2 (ja) | 2018-09-24 | 2019-09-24 | アルギナーゼ１ポリペプチド |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12194081B2 (enExample) |
| EP (1) | EP3856899A1 (enExample) |
| JP (1) | JP7624388B2 (enExample) |
| KR (1) | KR20210091696A (enExample) |
| CN (1) | CN112771159B (enExample) |
| AU (1) | AU2019350356B9 (enExample) |
| CA (1) | CA3113004A1 (enExample) |
| GB (1) | GB201815549D0 (enExample) |
| IL (1) | IL281762A (enExample) |
| MX (1) | MX2021003441A (enExample) |
| SG (1) | SG11202102378WA (enExample) |
| WO (1) | WO2020064744A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201818576D0 (en) | 2018-11-14 | 2018-12-26 | Io Biotech Aps | Arginase 2 polypeptides |
| US20250327041A1 (en) | 2022-02-24 | 2025-10-23 | Io Biotech Aps | Nucleotide delivery of cancer therapy |
| KR20240159833A (ko) | 2022-02-24 | 2024-11-06 | 아이오 바이오테크 에이피에스 | 아르기나아제 2 백신 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US58767A (en) | 1866-10-16 | John brougjbton | ||
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| US5780286A (en) | 1996-03-14 | 1998-07-14 | Smithkline Beecham Corporation | Arginase II |
| US20110111424A1 (en) | 2001-06-21 | 2011-05-12 | Cell Signaling Technology, Inc. | Analysis of ubiquitinated polypeptides |
| WO2003038444A2 (en) | 2001-10-31 | 2003-05-08 | Pfizer Products Inc. | Biomarkers of liver function |
| CA2836155A1 (en) | 2004-10-29 | 2006-05-11 | Board Of Trustees Of Michigan State University | Protection against herbivores |
| CA2742497C (en) | 2008-10-31 | 2024-01-23 | George Georgiou | Compositions of engineered human arginases and methods for treating cancer |
| CN101781369A (zh) * | 2009-01-20 | 2010-07-21 | 江苏先声药物研究有限公司 | 一种重组人精氨酸酶融合蛋白及其应用 |
| CN106456723B (zh) * | 2014-04-29 | 2021-03-09 | 康达医药科技有限公司 | 采用精氨酸酶i调节免疫系统的方法和组合物 |
| GB201501017D0 (en) | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| AU2017341112B2 (en) * | 2016-10-07 | 2024-06-27 | Io Biotech Aps | Immunogenic arginase peptides |
-
2018
- 2018-09-24 GB GBGB1815549.9A patent/GB201815549D0/en not_active Ceased
-
2019
- 2019-09-24 US US17/278,838 patent/US12194081B2/en active Active
- 2019-09-24 AU AU2019350356A patent/AU2019350356B9/en active Active
- 2019-09-24 CN CN201980062504.7A patent/CN112771159B/zh active Active
- 2019-09-24 MX MX2021003441A patent/MX2021003441A/es unknown
- 2019-09-24 CA CA3113004A patent/CA3113004A1/en active Pending
- 2019-09-24 KR KR1020217010964A patent/KR20210091696A/ko active Pending
- 2019-09-24 SG SG11202102378WA patent/SG11202102378WA/en unknown
- 2019-09-24 EP EP19779801.0A patent/EP3856899A1/en active Pending
- 2019-09-24 WO PCT/EP2019/075731 patent/WO2020064744A1/en not_active Ceased
- 2019-09-24 JP JP2021516368A patent/JP7624388B2/ja active Active
-
2021
- 2021-03-24 IL IL281762A patent/IL281762A/en unknown
-
2024
- 2024-11-01 US US18/935,162 patent/US20250205318A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8663651B2 (en) | T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation | |
| JP4422903B2 (ja) | 癌抑制遺伝子ｗｔ１の産物に基づく癌抗原 | |
| EP3094652B1 (en) | Novel vaccines against hpv and hpv-related diseases | |
| JP2018509935A5 (enExample) | ||
| CA2489227A1 (en) | Hla-a24-restricted cancer antigen peptides | |
| JP2022501046A5 (enExample) | ||
| JP2007516966A (ja) | 合成ｈｌａ結合ペプチド類似体及びその使用方法 | |
| JP2008530975A5 (enExample) | ||
| JP2022535102A5 (enExample) | ||
| JP2024513559A5 (enExample) | ||
| JP2022507373A5 (enExample) | ||
| JP2017530127A5 (enExample) | ||
| JP2019534884A5 (enExample) | ||
| JP2018506287A5 (enExample) | ||
| JP2009500298A5 (enExample) | ||
| EP2766384B1 (en) | Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response | |
| CA2432971A1 (en) | Polypeptides | |
| US20200062811A1 (en) | Yap protein inhibiting polypeptide and application thereof | |
| CN113164554A (zh) | 包含寡肽作为活性成分的用于预防或治疗癌症的药物组合物 | |
| JPWO2020071551A5 (enExample) | ||
| CN105524139A (zh) | 高活性的肿瘤抑制剂及其制法和应用 | |
| WO2018037246A4 (en) | Immunogenic composition | |
| JP2023502843A5 (enExample) | ||
| DE10006033A1 (de) | Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen | |
| CN101550185B (zh) | 新的肿瘤相关基因或蛋白及其应用 |